Showing results (321-330 of 454) with videos related to

Sort By:
Pageof 46
Circulation Research|October 18, 2014
Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery diseaseRiyaz S Patel, Qunna Li, Nima Ghasemzadeh, et al.
Blood|April 20, 2022
Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expressionJingru Zhu, Yitong Wang, Jingxia Li, et al.
Science (New York, N.Y.)|August 15, 2020
Influenza vaccine-induced human bone marrow plasma cells decline within a year after vaccinationCarl W Davis, Katherine J L Jackson, Megan M McCausland, et al.
Blood|September 20, 2017
Ibrutinib for chronic graft-versus-host disease after failure of prior therapyDavid Miklos, Corey S Cutler, Mukta Arora, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2021
Associations Between Inflammation, Cardiovascular Regenerative Capacity, and Cardiovascular Events: A Cohort StudyZakaria Almuwaqqat, Jeong Hwan Kim, Mariana Garcia, et al.
Bone Marrow Transplantation|August 1, 1997
Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiationR B Geller, S M Devine, K O'Toole, et al.
Blood Advances|July 24, 2019
Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusionMichael R Bishop, Richard T Maziarz, Edmund K Waller, et al.
Blood|October 21, 2016
Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cellsScott N Furlan, Benjamin Watkins, Victor Tkachev, et al.
Transplantation and Cellular Therapy|March 27, 2026
Transportability to the European population of Efficacy of Belumosudil as Compared with Physician's Choice of Best Available Therapy for The Treatment of Chronic Graft Versus Host DiseaseDaniel Wolff, Carlos Solano, David Michonneau, et al.
American Heart Journal|December 21, 2010
CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependentArshed A Quyyumi, Edmund K Waller, Jonathan Murrow, et al.
Pageof 46